• Valion Bio set a 1-for-25 reverse stock split, effective Aug. 31 at 12:01 a.m. ET.
• Shares expected to trade split-adjusted at the open on Aug. 31 under Nasdaq symbol VBIO.
• Move targets Nasdaq’s $1 minimum bid-price rule; company faces a Sept. 15 compliance deadline.
• Reverse split rounds fractional shares up to whole shares; no cash paid for fractions.
• Post-split common stock CUSIP will be 918942202.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valion Bio Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608270830ACCESSWRNAPR_____1213064) on August 27, 2026, and is solely responsible for the information contained therein.